Loading...
Levetiracetam induced acute reversible psychosis in a patient with uncontrolled seizures
Levetiracetam (LEV) is a relatively newer antiepileptic drug with novel mechanism of action. It was introduced to the market in the year 2000. Pre-marketing clinical trials of the drug reported good tolerability with a wide safety margin. On post-marketing updates, there are few reports of psychosis...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4175900/ https://ncbi.nlm.nih.gov/pubmed/25298593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.140599 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|